A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients

To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.

NCT Number	NCT07322367
Lead Sponsor	Wake Forest University Health Sciences Collaborators: National Cancer Institute (NCI)
Conditions	Lung Cancer
Enrollment	27,000 participants
Start Date	2026-03-25
Primary Completion	2027-01 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-25